291 related articles for article (PubMed ID: 1370193)
1. Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
Weaver MG; Abdul-Karim FW; Srigley J; Bostwick DG; Ro JY; Ayala AG
Am J Surg Pathol; 1992 Jan; 16(1):62-8. PubMed ID: 1370193
[TBL] [Abstract][Full Text] [Related]
2. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.
Adlakha H; Bostwick DG
Hum Pathol; 1994 Feb; 25(2):135-9. PubMed ID: 7509774
[TBL] [Abstract][Full Text] [Related]
3. Paneth cell-like change and small cell carcinoma of the prostate. Two divergent forms of prostatic neuroendocrine differentiation.
Weaver MG; Abdul-Karim FW; Srigley JR
Am J Surg Pathol; 1992 Oct; 16(10):1013-6. PubMed ID: 1329569
[TBL] [Abstract][Full Text] [Related]
4. Unusual prostatic adenocarcinoma with endocrine basophilic FSH-immunoreactive cells.
Serio G; Zampatti C; Rindi G
Virchows Arch; 2000 Jun; 436(6):628-33. PubMed ID: 10917180
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1 in eosinophilic metaplasia of the prostate.
Koleva M; Dikov D; Belovejdov V; Sarafian V
Prostate; 2019 May; 79(6):622-627. PubMed ID: 30652335
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic metaplasia of the prostate: a newly described lesion distinct from other eosinophilic changes in prostatic epithelium.
Cheng L; MacLennan GT; Abdul-Karim FW; Lopez-Beltran A; Montironi R
Anal Quant Cytol Histol; 2008 Aug; 30(4):226-30. PubMed ID: 18773741
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic endocrine cells in prostatic carcinoma: a case report with immunocytochemical and electron microscopic findings.
Watanabe K; Hoshi N; Hiraki H; Yamaki T; Tsu-Ura Y; Suzuki T
Fukushima J Med Sci; 1995 Jun; 41(1):51-60. PubMed ID: 8606042
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
[TBL] [Abstract][Full Text] [Related]
9. Paneth cell-like metaplasia of the prostate gland.
Frydman CP; Bleiweiss IJ; Unger PD; Gordon RE; Brazenas NV
Arch Pathol Lab Med; 1992 Mar; 116(3):274-6. PubMed ID: 1371381
[TBL] [Abstract][Full Text] [Related]
10. Unusual histologic types of high-grade prostatic intraepithelial neoplasia.
Reyes AO; Swanson PE; Carbone JM; Humphrey PA
Am J Surg Pathol; 1997 Oct; 21(10):1215-22. PubMed ID: 9331295
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma.
Cohen RJ; McNeal JE; Edgar SG; Robertson T; Dawkins HJ
Hum Pathol; 1998 Dec; 29(12):1488-94. PubMed ID: 9865837
[TBL] [Abstract][Full Text] [Related]
13. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
Warhol MJ; Longtine JA
J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?
Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL
Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.
Bostwick DG; Dousa MK; Crawford BG; Wollan PC
Am J Surg Pathol; 1994 Dec; 18(12):1240-6. PubMed ID: 7977947
[TBL] [Abstract][Full Text] [Related]
17. Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
Constantinides C; Pavlaki K; Zizi D; Gavriel J; Mitropoulos D; Garifalos J; Dimopoulos C
Urol Int; 1995; 55(3):134-6. PubMed ID: 8540155
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
[TBL] [Abstract][Full Text] [Related]
19. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
